Effects of puerarin on rats with type 2 diabetes mellitus.
10.12047/j.cjap.5786.2019.075
- Author:
Fei YANG
1
;
Xin-Xin DONG
2
;
Yun GUO
1
Author Information
1. Department of Endocrinology, Characteristic Medical Center of the Chinese People's Armed Police Force, Tianjin 300162.
2. Department of Surgical Oncology, Characteristic Medical Center of the Chinese People's Armed Police Force, Tianjin 300162, China.
- Publication Type:Journal Article
- MeSH:
Animals;
Blood Glucose;
Diabetes Mellitus, Experimental;
drug therapy;
Diabetes Mellitus, Type 2;
drug therapy;
Isoflavones;
pharmacology;
Lipids;
blood;
Random Allocation;
Rats;
Streptozocin;
Weight Loss
- From:
Chinese Journal of Applied Physiology
2019;35(4):355-358
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To investigate the therapeutic effects of puerarin on rats with type 2 diabetes mellitus (T2DM).
METHODS:T2DM models were established by high fat and high glucose feeding combined with a one-time intraperitoneal injection of streptozotocin (STZ, 60 mg/kg). Then the rats were randomly divided into normal group, model group, metformin group (MET, 40 mg/kg), puerarin low-dose group, medium-dose group and high-dose group (40, 80, 160 mg/kg), n=10. After the model was successfully established, rats were treated with corresponding drug intervention by intragastrical administration for 4 weeks. The body weight and fasting blood glucose (FBG) were measured per week, and blood samples were collected 24 h after the last administration, and serum levels of blood glucose, serum triglyceride (TG), total cholesterol (TC), low-density lipoprotein-cholesterol (LDL-C), high-density lipoprotein-cholestrol (HDL-C), serum enzyme activities of aspartate aminotransferase (AST), alanine aminotransferase (ALT), blood urea nitrogen (BUN), serum creatinine (SCr), and blood uric acid (UA) were measured.
RESULTS:As compared with normal group, the body weight was decreased after 4 weeks-intervention in the model group, and the levels of FBG, TC, TG, LDL-C, ALT, AST, BUN, SCr and UA were all increased,while HDL-C level was decreased (P＜0.05). As compared with model group,the body weight was increased after 4 weeks-intervention in metformin group and puerarin groups, and the levels of FBG, TC, TG, LDL-C, ALT, AST, BUN, SCr and UA were decreased (P＜0.01); meanwhile, HDL-C level was increased significantly (P＜0.05).
CONCLUSION:Puerarin can reduce the weight loss of T2DM rats, decrease the blood lipid and blood glucose levels of T2DM rats, which can be used to control T2DM.
